» Articles » PMID: 36714222

Lack of Accelerated Ovarian Aging in a Follicle-stimulating Hormone Receptor Haploinsufficiency Model

Overview
Specialty Geriatrics
Date 2023 Jan 30
PMID 36714222
Authors
Affiliations
Soon will be listed here.
Abstract

Follicle-stimulation hormone (FSH) and FSH receptor (FSHR) signaling is essential for lifelong ovarian and endocrine functions in females. Previous studies have reported that haploinsufficiency in female mice led to accelerated ovarian aging, including anticipated progressive fertility decline, irregular estrus cycles, increased follicular atresia and premature ovarian failure at 7 to 9 months of age. Interestingly, these phenotypes resemble key characteristics of human menopause and thus haploinsufficiency was proposed as a promising research mouse model of menopause. However, the haploinsufficiency model had not been fully explored, especially at the molecular level. In this study, we characterized the ovarian and endocrine functions of a heterozygous knockout allele that was generated on the C57BL/6 genetic background as part of the Knockout Mouse Project (KOMP). Based on our analyses of these mice using a breeding assay, ovarian tissue histology and serum hormone quantifications ( FSH, AMH, INHA) analyses, the KOMP heterozygous knockout female mice do not show the anticipated phenotypes of ovarian aging in terms of fertility and endocrine function. We further confirmed that the expression of is unaltered in the ovaries of the KOMP heterozygous knockout animals compared to wild-type. Together, our data suggests that the KOMP heterozygous knockout strain does not recapitulate the previously reported ovarian aging phenotypes associated to another model of haploinsufficiency.

Citing Articles

Estropausal gut microbiota transplant improves measures of ovarian function in adult mice.

Kim M, Wang J, Pilley S, Lu R, Xu A, Kim Y bioRxiv. 2025; .

PMID: 40060387 PMC: 11888174. DOI: 10.1101/2024.05.03.592475.


CCDC134 enhances ovarian reserve function and angiogenesis by directly interacting with INHA in a mouse model of premature ovarian insufficiency.

Cui X, Li H, Zhu X, Huang X, Xue T, Wang S Apoptosis. 2025; .

PMID: 40042746 DOI: 10.1007/s10495-025-02092-2.

References
1.
Te Velde E, Scheffer G, Dorland M, Broekmans F, Fauser B . Developmental and endocrine aspects of normal ovarian aging. Mol Cell Endocrinol. 1999; 145(1-2):67-73. DOI: 10.1016/s0303-7207(98)00171-3. View

2.
Vihko K . Gonadotropins and ovarian gonadotropin receptors during the perimenopausal transition period. Maturitas. 1996; 23 Suppl:S19-22. DOI: 10.1016/0378-5122(96)01006-7. View

3.
Festing M . Inbred mice in research. Nature. 1969; 221(5182):716. DOI: 10.1038/221716a0. View

4.
Dierich A, Sairam M, Monaco L, Fimia G, Gansmuller A, Lemeur M . Impairing follicle-stimulating hormone (FSH) signaling in vivo: targeted disruption of the FSH receptor leads to aberrant gametogenesis and hormonal imbalance. Proc Natl Acad Sci U S A. 1998; 95(23):13612-7. PMC: 24867. DOI: 10.1073/pnas.95.23.13612. View

5.
Kevenaar M, Meerasahib M, Kramer P, van de Lang-Born B, de Jong F, Groome N . Serum anti-mullerian hormone levels reflect the size of the primordial follicle pool in mice. Endocrinology. 2006; 147(7):3228-34. DOI: 10.1210/en.2005-1588. View